X
Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!
Buying the index now will hardly help make money in stocks even in ten years.
Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.
Sluggish Credit Offtake pulls down Net Interest Income for Banks.
PersonalFN simplifies the mutual fund account statement for you.
A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.
Mr Trump is in the White House and the gods are in their heavens; what's not to like?
The bitcoin has given humongous returns to the tune of 4051% in the last four years. Will the rally continue?
The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?
All across the country, the old gods become devils. New, gluten-free gods take their places...
And what it has in common with beating the stock market too.
Price wars and regulatory issues have ensured continuous underperformance of the sector.
Ensure your financial Independence, and pledge to start the journey towards financial freedom today!
Last week's correction is making a number of Super Investor stocks look a lot more attractive...
It is because the negative effects of the waivers aren't clearly visible.
India's services sector increases contribution to GDP, but lags in job creation.
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
What is Equitymaster Insider Ankit Shah stealing from Berkshire's success?
Will the potential growth in roadways offer megatrend like opportunities to investors?
Pharma stocks are bearing the brunt of increased regulatory pressure from USFDA.
This is what led value investors Mohnish Pabrai and Warren Buffett to their first million and billion.
|
| |
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | Advertise | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
